T. Harrower, T. Foltynie, L. Kartsounis, R.N. De Silva and J.R. Hodges, “A case of voltage-gated potassium channel antibody-related limbic encephalitis,” Nat Clin Pract Neurol, Vol. 2, No. 6, 2006, pp. 339-343.
 F. Ferracci, G. Fassetta, M.H. Butler, S. Floyd, M. Solimena and P. De Camilli, “A novel antineuronal antibody in a motor neuron syndrome associated with breast cancer,” Neurology, Vol. 53, No. 4, 1999, pp. 852-855.
 B.K. Evans, C. Fagan, T. Arnold, E.J. Dropcho and S.J. Oh, “Paraneoplastic motor neuron disease and renal cell carcinoma: improvement after nephrectomy,” Neurology, Vol. 40, No. 6, 1990, pp. 960-962.
 R.G. Weleber, R.C. Watzke, W.T. Shults, K.M. Trzupek, J.R. Heckenlively, R.A. Egan and G. Adamus, “Clinical and electrophysiologic characterization of paraneoplastic and autoimmune retinopathies associated with antienolase antibodies,” Am J Ophthalmol, Vol. 139, No. 5, 2005, pp. 780-794.
 S. Karimi-Abdolrezaee, E. Eftekharpour and M.G. Fehlings, “Temporal and spatial patterns of Kv1.1 and Kv1.2 protein and gene expression in spinal cord white matter after acute and chronic spinal cord injury in rats: implications for axonal pathophysiology after neurotrauma,” Eur J Neurosci, Vol. 19, No. 3, 2004, pp. 577-589.
 R. Nashmi and M.G. Fehlings, “Mechanisms of axonal dysfunction after spinal cord injury: with an emphasis on the role of voltage-gated potassium channels,” Brain Res Brain Res Rev, Vol. 38, No. 1-2, 2001, pp. 165-191.